Bowman-Birk Inhibitors: Insights into Family of Multifunctional Proteins and Peptides with Potential Therapeutical Applications

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2020 Dec 1

PMID 33255583

Citations 27

Authors

Agata Gitlin-Domagalska

Aleksandra Maciejewska

Dawid Debowski

Affiliations

Soon will be listed here.

Abstract

Bowman-Birk inhibitors (BBIs) are found primarily in seeds of legumes and in cereal grains. These canonical inhibitors share a highly conserved nine-amino acids binding loop motif CTP1SXPPXC (where P1 is the inhibitory active site, while X stands for various amino acids). They are natural controllers of plants' endogenous proteases, but they are also inhibitors of exogenous proteases present in microbials and insects. They are considered as plants' protective agents, as their elevated levels are observed during injury, presence of pathogens, or abiotic stress, i.a. Similar properties are observed for peptides isolated from amphibians' skin containing 11-amino acids disulfide-bridged loop CWTP1SXPPXPC. They are classified as Bowman-Birk like trypsin inhibitors (BBLTIs). These inhibitors are resistant to proteolysis and not toxic, and they are reported to be beneficial in the treatment of various pathological states. In this review, we summarize up-to-date research results regarding BBIs' and BBLTIs' inhibitory activity, immunomodulatory and anti-inflammatory activity, antimicrobial and insecticidal strength, as well as chemopreventive properties.

Citing Articles

Molecular Chimera in Cancer Drug Discovery: Beyond Antibody Therapy, Designing Grafted Stable Peptides Targeting Cancer.

Chowdhury A, Shrestha P, Jois S Int J Pept Res Ther. 2025; 31(3):38.

PMID: 39974747 PMC: 11832722. DOI: 10.1007/s10989-025-10690-6.

Genome editing, an opportunity to revive soybean cultivation in Europe.

Monfort M, Buitink J, Roeber F, Nogue F Plant J. 2025; 121(4):e17266.

PMID: 39968624 PMC: 11836770. DOI: 10.1111/tpj.17266.

Cytotoxic Effects of Plant Secondary Metabolites and Naturally Occurring Bioactive Peptides on Breast Cancer Model Systems: Molecular Mechanisms.

Zasheva D, Mladenov P, Zapryanova S, Gospodinova Z, Georgieva M, Alexandar I Molecules. 2024; 29(22).

PMID: 39598664 PMC: 11596968. DOI: 10.3390/molecules29225275.

Enhancing health and therapeutic potential: innovations in the medicinal and pharmaceutical properties of soy bioactive compounds.

Rahman U, Younas Z, Ahmad I, Yousaf T, Latif R, Rubab U Front Pharmacol. 2024; 15:1397872.

PMID: 39421675 PMC: 11483366. DOI: 10.3389/fphar.2024.1397872.

Enzyme Inhibitors as Multifaceted Tools in Medicine and Agriculture.

Del Prete S, Pagano M Molecules. 2024; 29(18).

PMID: 39339309 PMC: 11433695. DOI: 10.3390/molecules29184314.

References

Malkowicz S, McKenna W, Vaughn D, Wan X, Propert K, Rockwell K . Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. Prostate. 2001; 48(1):16-28. DOI: 10.1002/pros.1077. View

James A, Jayasena A, Zhang J, Berkowitz O, Secco D, Knott G . Evidence for Ancient Origins of Bowman-Birk Inhibitors from . Plant Cell. 2017; 29(3):461-473. PMC: 5385957. DOI: 10.1105/tpc.16.00831. View

Swedberg J, Yi Li C, de Veer S, Wang C, Craik D . Design of Potent and Selective Cathepsin G Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold. J Med Chem. 2017; 60(2):658-667. DOI: 10.1021/acs.jmedchem.6b01509. View

de Azevedo Pereira R, Valencia-Jimenez A, Magalhaes C, Prates M, Melo J, de Lima L . Effect of a Bowman-Birk proteinase inhibitor from Phaseolus coccineus on Hypothenemus hampei gut proteinases in vitro. J Agric Food Chem. 2007; 55(26):10714-9. DOI: 10.1021/jf072155x. View

Wang T, Jiang Y, Chen X, Wang L, Ma C, Xi X . Ranacyclin-NF, a Novel Bowman-Birk Type Protease Inhibitor from the Skin Secretion of the East Asian Frog, . Biology (Basel). 2020; 9(7). PMC: 7407945. DOI: 10.3390/biology9070149. View

Singh S, Singh A, Kumar S, Mittal P, Singh I . Protease inhibitors: recent advancement in its usage as a potential biocontrol agent for insect pest management. Insect Sci. 2018; 27(2):186-201. DOI: 10.1111/1744-7917.12641. View

Dantzger M, Vasconcelos I, Scorsato V, Aparicio R, Marangoni S, Macedo M . Bowman-Birk proteinase inhibitor from Clitoria fairchildiana seeds: Isolation, biochemical properties and insecticidal potential. Phytochemistry. 2015; 118:224-35. DOI: 10.1016/j.phytochem.2015.08.013. View

Clemente A, Arques M . Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents. World J Gastroenterol. 2014; 20(30):10305-15. PMC: 4130838. DOI: 10.3748/wjg.v20.i30.10305. View

Fields C, Mallee P, Muzard J, Lee G . Isolation of Bowman-Birk-Inhibitor from soybean extracts using novel peptide probes and high gradient magnetic separation. Food Chem. 2013; 134(4):1831-8. DOI: 10.1016/j.foodchem.2012.03.085. View

10.

Armstrong W, Kennedy A, Wan X, Atiba J, McLaren C, Meyskens Jr F . Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia. Cancer Epidemiol Biomarkers Prev. 2000; 9(1):43-7. View

11.

Clemente A, Moreno F, Marin-Manzano M, Jimenez E, Domoney C . The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases. Mol Nutr Food Res. 2009; 54(3):396-405. DOI: 10.1002/mnfr.200900122. View

12.

Lin L, Mick R, Ware J, Metz J, Lustig R, Vapiwala N . Phase I randomized double-blind placebo-controlled single-dose safety studies of Bowman-Birk inhibitor concentrate. Oncol Lett. 2014; 7(4):1151-1158. PMC: 3961219. DOI: 10.3892/ol.2014.1855. View

13.

Armstrong W, Kennedy A, Wan X, Taylor T, Nguyen Q, Jensen J . Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial. Clin Cancer Res. 2001; 6(12):4684-91. View

14.

Tang M, Asamoto M, Ogawa K, Naiki-Ito A, Sato S, Takahashi S . Induction of apoptosis in the LNCaP human prostate carcinoma cell line and prostate adenocarcinomas of SV40T antigen transgenic rats by the Bowman-Birk inhibitor. Pathol Int. 2009; 59(11):790-6. DOI: 10.1111/j.1440-1827.2009.02445.x. View

15.

Debowski D, Cichorek M, Lubos M, Wojcik S, Legowska A, Rolka K . Noncovalent inhibitors of human 20S and 26S proteasome based on trypsin inhibitor SFTI-1. Biopolymers. 2016; 106(5):685-96. DOI: 10.1002/bip.22886. View

16.

Zhang L, Wan X, Donahue J, Ware J, Kennedy A . Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells. Nutr Cancer. 1999; 33(2):165-73. DOI: 10.1207/S15327914NC330208. View

17.

Shan L, Li C, Chen F, Zhao S, Xia G . A Bowman-Birk type protease inhibitor is involved in the tolerance to salt stress in wheat. Plant Cell Environ. 2008; 31(8):1128-37. DOI: 10.1111/j.1365-3040.2008.01825.x. View

18.

Sakurai N, Suzuki K, Nagaoka T, Saito T, Yoshimura H, Yano T . Connexin 43-dependent tumor-suppressing effect of the Bowman-Birk protease inhibitor on M5076 ovarian sarcoma-bearing mice. Mol Med Rep. 2011; 1(5):689-93. DOI: 10.3892/mmr_00000014. View

19.

de Veer S, Yi Li C, Swedberg J, Schroeder C, Craik D . Engineering potent mesotrypsin inhibitors based on the plant-derived cyclic peptide, sunflower trypsin inhibitor-1. Eur J Med Chem. 2018; 155:695-704. DOI: 10.1016/j.ejmech.2018.06.029. View

20.

Hou S, Jamieson P, He P . The cloak, dagger, and shield: proteases in plant-pathogen interactions. Biochem J. 2018; 475(15):2491-2509. DOI: 10.1042/BCJ20170781. View